内容摘要：During nurse Aguirre’s vaccination drive, one man simply said people here “prefer to cure themselves in their own way.” A mother described getting sick with measles as a “privilege” and spoke of putting her unvaccinated 5- and 7-year-olds in a party so everyone could get sick and recover — a risky tactic doctors have long denounced.

During nurse Aguirre’s vaccination drive, one man simply said people here “prefer to cure themselves in their own way.” A mother described getting sick with measles as a “privilege” and spoke of putting her unvaccinated 5- and 7-year-olds in a party so everyone could get sick and recover — a risky tactic doctors have long denounced.

Hoeg — along with Makary and Prasad — spent much of the COVID-19 pandemic criticizing the FDA’s handling of booster shots, particularly in children and young adults. All three were co-authors of a 2022 paper stating that requiring booster shots in young people would cause more harm than benefit.Novavax isn’t the only vaccine manufacturer already affected by changing attitudes at FDA. Earlier this month, Moderna pushed back the target date for its new COVID-and-flu combination vaccine to next year after the FDA requested additional effectiveness data.

As the FDA’s top official overseeing vaccines, Prasad is now in position to reverse what he recently called “a number of missteps” in how the FDA assessed the benefits and risks of COVID-19 boosters.He questioned how much benefit yearly vaccinations continue to offer. In a podcast shortly before assuming his FDA job, Prasad suggested companies could study about 20,000 older adults in August or September to show if an updated vaccine prevented COVID-related hospitalizations.There is “legitimate debate about who should be boosted, how frequently they should be boosted and the value of boosting low-risk individuals,” said Hopkins’ Adalja. But he stressed that CDC’s Advisory Committee on Immunization Practices has the proper expertise to be making those decisions.

And other experts say simply updating the strain that a COVID-19 vaccine targets doesn’t make it a new product — and real-world data shows each fall’s update has offered benefit.“The data are clear and compelling” that vaccination reduces seniors’ risk of hospitalization and serious illness for four to six months, said Michael Osterholm, a University of Minnesota infectious disease researcher.

Nor could that kind of study be accomplished quickly enough to get millions of people vaccinated before the yearly winter surge, said Dr. Jesse Goodman of Georgetown University, a former FDA vaccine chief.

“You’d always be doing clinical trials and you’d never have a vaccine that was up to date,” he said.“Such a politicized and discriminatory action lays bare the U.S. lie that it upholds so-called freedom and openness,” she said Thursday, adding that China has lodged a protest with the U.S.

The issue of Chinese students studying overseas has long been a point of tension in the bilateral relationship. In 2019, during Trump’s first term, China’s Ministry of Education warned students about visa issues in the U.S., with rising rejection rates and shortening of visas.Last year, the Chinese Foreign Ministry protested that a number of

upon arrival at U.S. airports.Chinese state media has long hyped gun violence in the U.S. and violent protests during the pandemic, and portrayed the U.S. as a dangerous place that wasn’t safe for its citizens. The tense bilateral relationship has also meant that some